Department of Urology,
Veterans Affairs Medical Center,
San Francisco,
Department of Urology, Veterans Affairs Medical Center, San Francisco
Soichiro Yamamura has not added Biography.
If you are Soichiro Yamamura and would like to personalize this page please email our Author Liaison for assistance.
Coordination of p300-mediated chromatin remodeling and TRAP/mediator function through coactivator PGC-1alpha.
Molecular cell Nov, 2003 | Pubmed ID: 14636573
E protein silencing by the leukemogenic AML1-ETO fusion protein.
Science (New York, N.Y.) Aug, 2004 | Pubmed ID: 15333839
Structural and functional organization of TRAP220, the TRAP/mediator subunit that is targeted by nuclear receptors.
Molecular and cellular biology Sep, 2004 | Pubmed ID: 15340084
Sphingosine 1-phosphate breakdown in platelets.
Journal of biochemistry Oct, 2004 | Pubmed ID: 15625319
MED1/TRAP220 exists predominantly in a TRAP/ Mediator subpopulation enriched in RNA polymerase II and is required for ER-mediated transcription.
Molecular cell Jul, 2005 | Pubmed ID: 15989967
Wnt antagonist gene polymorphisms and renal cancer.
Cancer Oct, 2009 | Pubmed ID: 19562778
Functional significance of secreted Frizzled-related protein 1 in metastatic renal cell carcinomas.
Cancer research Sep, 2009 | Pubmed ID: 19723665
Wnt antagonist gene DKK2 is epigenetically silenced and inhibits renal cancer progression through apoptotic and cell cycle pathways.
Clinical cancer research : an official journal of the American Association for Cancer Research Sep, 2009 | Pubmed ID: 19755393
Restoring erectile function by antioxidant therapy in diabetic rats.
The Journal of urology Nov, 2009 | Pubmed ID: 19765757
Functional significance of Wnt inhibitory factor-1 gene in kidney cancer.
Cancer research Nov, 2009 | Pubmed ID: 19887605
Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.
Cancer research Apr, 2010 | Pubmed ID: 20332239
Secreted frizzled-related protein-5 is epigenetically downregulated and functions as a tumor suppressor in kidney cancer.
International journal of cancer. Journal international du cancer Feb, 2011 | Pubmed ID: 20340127
Oncogenic functions of secreted Frizzled-related protein 2 in human renal cancer.
Molecular cancer therapeutics Jun, 2010 | Pubmed ID: 20501806
Wnt antagonist DKK1 acts as a tumor suppressor gene that induces apoptosis and inhibits proliferation in human renal cell carcinoma.
International journal of cancer. Journal international du cancer Apr, 2011 | Pubmed ID: 20549706
MicroRNA-205-directed transcriptional activation of tumor suppressor genes in prostate cancer.
Cancer Dec, 2010 | Pubmed ID: 20737563
Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.
Clinical cancer research : an official journal of the American Association for Cancer Research Aug, 2011 | Pubmed ID: 21159887
MicroRNA-205 inhibits Src-mediated oncogenic pathways in renal cancer.
Cancer research Apr, 2011 | Pubmed ID: 21330408
MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer.
Carcinogenesis May, 2011 | Pubmed ID: 21349819
Curcumin modulates microRNA-203-mediated regulation of the Src-Akt axis in bladder cancer.
Cancer prevention research (Philadelphia, Pa.) Oct, 2011 | Pubmed ID: 21836020
MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells.
Cancer research Oct, 2011 | Pubmed ID: 21852381
Tumor suppressor microRNA-493 decreases cell motility and migration ability in human bladder cancer cells by downregulating RhoC and FZD4.
Molecular cancer therapeutics Jan, 2012 | Pubmed ID: 22057916
MicroRNA-34a suppresses malignant transformation by targeting c-Myc transcriptional complexes in human renal cell carcinoma.
Carcinogenesis Feb, 2012 | Pubmed ID: 22159222
Catechol-O-methyltransferase-mediated metabolism of 4-hydroxyestradiol inhibits the growth of human renal cancer cells through the apoptotic pathway.
Carcinogenesis Feb, 2012 | Pubmed ID: 22159223
MicroRNA-34a modulates c-Myc transcriptional complexes to suppress malignancy in human prostate cancer cells.
PloS one , 2012 | Pubmed ID: 22235332
Up-regulation of microRNA-21 correlates with lower kidney cancer survival.
PloS one , 2012 | Pubmed ID: 22347428
miRNA-708 control of CD44(+) prostate cancer-initiating cells.
Cancer research Jul, 2012 | Pubmed ID: 22552290
Genistein suppresses prostate cancer growth through inhibition of oncogenic microRNA-151.
PloS one , 2012 | Pubmed ID: 22928040
MicroRNA-1280 inhibits invasion and metastasis by targeting ROCK1 in bladder cancer.
PloS one , 2012 | Pubmed ID: 23056431
miR-23b represses proto-oncogene Src kinase and functions as methylation-silenced tumor suppressor with diagnostic and prognostic significance in prostate cancer.
Cancer research Dec, 2012 | Pubmed ID: 23074286
miRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications, and AKT pathways.
Clinical cancer research : an official journal of the American Association for Cancer Research Jan, 2013 | Pubmed ID: 23147995
Genistein up-regulates tumor suppressor microRNA-574-3p in prostate cancer.
PloS one , 2013 | Pubmed ID: 23554959
Hrk mediates 2-methoxyestradiol-induced mitochondrial apoptotic signaling in prostate cancer cells.
Molecular cancer therapeutics Jun, 2013 | Pubmed ID: 23580416
MicroRNA-23b functions as a tumor suppressor by regulating Zeb1 in bladder cancer.
PloS one , 2013 | Pubmed ID: 23844063
Genistein inhibits prostate cancer cell growth by targeting miR-34a and oncogenic HOTAIR.
PloS one , 2013 | Pubmed ID: 23936419
MicroRNA-4723 inhibits prostate cancer growth through inactivation of the Abelson family of nonreceptor protein tyrosine kinases.
PloS one , 2013 | Pubmed ID: 24223753
Long non-coding RNA HOTAIR is targeted and regulated by miR-141 in human cancer cells.
The Journal of biological chemistry May, 2014 | Pubmed ID: 24616104
Regulation of SRC kinases by microRNA-3607 located in a frequently deleted locus in prostate cancer.
Molecular cancer therapeutics Jul, 2014 | Pubmed ID: 24817628
Cytochrome P450 1B1 polymorphisms and risk of renal cell carcinoma in men.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine Oct, 2014 | Pubmed ID: 25027399
DNA mismatch repair gene MLH1 induces apoptosis in prostate cancer cells.
Oncotarget Nov, 2014 | Pubmed ID: 25526032
Inactivation of bone morphogenetic protein 2 may predict clinical outcome and poor overall survival for renal cell carcinoma through epigenetic pathways.
Oncotarget Apr, 2015 | Pubmed ID: 25797254
Loss of miR-200c up-regulates CYP1B1 and confers docetaxel resistance in renal cell carcinoma.
Oncotarget Apr, 2015 | Pubmed ID: 25860934
Functional role of DNA mismatch repair gene PMS2 in prostate cancer cells.
Oncotarget Jun, 2015 | Pubmed ID: 26036629
CYP1B1 promotes tumorigenesis via altered expression of CDC20 and DAPK1 genes in renal cell carcinoma.
BMC cancer , 2015 | Pubmed ID: 26626260
Functional role and tobacco smoking effects on methylation of CYP1A1 gene in prostate cancer.
Oncotarget May, 2016 | Pubmed ID: 27203547
ACERCA DE JoVE
Copyright © 2024 MyJoVE Corporation. Todos los derechos reservados